DK161076C - 2-(2-thienyl-imidazooe4,5-baapyridin-derivater og syreadditionssalte deraf samt farmaceutisk formulering indeholdende en saadan forbindelse - Google Patents

2-(2-thienyl-imidazooe4,5-baapyridin-derivater og syreadditionssalte deraf samt farmaceutisk formulering indeholdende en saadan forbindelse

Info

Publication number
DK161076C
DK161076C DK538084A DK538084A DK161076C DK 161076 C DK161076 C DK 161076C DK 538084 A DK538084 A DK 538084A DK 538084 A DK538084 A DK 538084A DK 161076 C DK161076 C DK 161076C
Authority
DK
Denmark
Prior art keywords
imidazooe4
baapyridine
thienyl
derivatives
compound
Prior art date
Application number
DK538084A
Other languages
English (en)
Other versions
DK538084D0 (da
DK538084A (da
DK161076B (da
Inventor
Dieter Binder
Franz Rovenszky
Original Assignee
Hafslund Nycomed Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hafslund Nycomed Pharma filed Critical Hafslund Nycomed Pharma
Publication of DK538084D0 publication Critical patent/DK538084D0/da
Publication of DK538084A publication Critical patent/DK538084A/da
Publication of DK161076B publication Critical patent/DK161076B/da
Application granted granted Critical
Publication of DK161076C publication Critical patent/DK161076C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK538084A 1983-11-14 1984-11-13 2-(2-thienyl-imidazooe4,5-baapyridin-derivater og syreadditionssalte deraf samt farmaceutisk formulering indeholdende en saadan forbindelse DK161076C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0399983A AT379395B (de) 1983-11-14 1983-11-14 Verfahren zur herstellung von neuen 2(2-thienyl)-imidazo (4,5-b) pyridin-derivaten und deren pharmazeutisch vertraeglichen saeureadditionssalzen
AT399983 1983-11-14

Publications (4)

Publication Number Publication Date
DK538084D0 DK538084D0 (da) 1984-11-13
DK538084A DK538084A (da) 1985-05-15
DK161076B DK161076B (da) 1991-05-27
DK161076C true DK161076C (da) 1991-11-18

Family

ID=3558281

Family Applications (1)

Application Number Title Priority Date Filing Date
DK538084A DK161076C (da) 1983-11-14 1984-11-13 2-(2-thienyl-imidazooe4,5-baapyridin-derivater og syreadditionssalte deraf samt farmaceutisk formulering indeholdende en saadan forbindelse

Country Status (9)

Country Link
US (1) US4596830A (da)
EP (1) EP0148742B1 (da)
JP (1) JPH0631233B2 (da)
AT (1) AT379395B (da)
CA (1) CA1247623A (da)
CS (1) CS332191A3 (da)
DE (1) DE3474962D1 (da)
DK (1) DK161076C (da)
FI (1) FI77863C (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ217755A (en) * 1985-10-09 1989-08-29 Chemie Linz Ag 2-(2-thienyl)-imidazo(4,5-c)pyridine derivatives and pharmaceutical compositions
DE60021065T2 (de) * 1999-03-31 2006-06-01 UAF Technologies and Research, LLC, Tucson Virus behandlung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1186504A (en) * 1966-10-15 1970-04-02 Fisons Pest Control Ltd Substituted Heterocyclic Compounds
DE2305339C3 (de) * 1973-02-03 1980-05-08 Dr. Karl Thomae Gmbh, 7950 Biberach Imidazo [4,5-b] pyridine, ihre Herstellung und ihre Verwendung als Cardiötonica
US4281005A (en) * 1979-03-05 1981-07-28 Merck & Co., Inc. Novel 2-pyridylimidazole compounds
DE3037464A1 (de) * 1980-10-03 1982-05-19 Dr. Karl Thomae Gmbh, 7950 Biberach 6-hydroxy-2-phenyl-imidazo 4,5-b zu pyridine, ihre herstellung und diese sie enthaltende arzneimittel
DE3273461D1 (en) * 1981-08-19 1986-10-30 Merck Patent Gmbh 2-arylimidazopyridines
DE3225386A1 (de) * 1982-07-07 1984-01-12 Beiersdorf Ag, 2000 Hamburg Substituierte naphthyl-imidazo (4,5-b) pyridine, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen

Also Published As

Publication number Publication date
EP0148742A1 (de) 1985-07-17
DK538084D0 (da) 1984-11-13
DK538084A (da) 1985-05-15
CS332191A3 (en) 1992-04-15
FI77863C (fi) 1989-05-10
AT379395B (de) 1985-12-27
JPS60116683A (ja) 1985-06-24
FI77863B (fi) 1989-01-31
FI844450L (fi) 1985-05-15
JPH0631233B2 (ja) 1994-04-27
DK161076B (da) 1991-05-27
US4596830A (en) 1986-06-24
ATA399983A (de) 1985-05-15
CA1247623A (en) 1988-12-28
FI844450A0 (fi) 1984-11-13
EP0148742B1 (de) 1988-11-02
DE3474962D1 (en) 1988-12-08

Similar Documents

Publication Publication Date Title
DK190885D0 (da) 2-(n-substitueret guanidino)-4-heteroarylthiazolderivater eller farmaceutisk acceptable syreadditionssalte deraf samt farmaceutisk praeparat indeholdende forbindelserne
DK165877C (da) 1,4-dihydro-6-fluor-4-oxo-1,8-naphthyridin-3-carboxylsyrederivater og salte deraf, antibakterielle praeparater indeholdende saadanne forbindelser
DK1790D0 (da) Laegemidler indeholdende insulinderivater
DK596083A (da) Carboxylsyreamidderivat, fremgangsmaade til fremstilling deraf samt laegemiddel indeholdende en saadan forbindelse
DE3863678D1 (de) Lithiumsalze enthaltende pharmazeutische zubereitungen.
DK170785A (da) 4-substituerede-piperazin-2-carboxylsyre-derivater og farmaceutisk acceptable salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og farmaceutiske praeparater indeholdende disse
DK522983D0 (da) Arylphenyletherderivater og syreadditionssalte deraf samt fremgangsmade til fremstilling deraf
DK285686A (da) Heterocykliske forbindelser som fungicider
DK157931C (da) 1,3-dihydro-6-methyl-7-hydroxy-furo-(3,4-c)-pyridinderivater og terapeutisk acceptable syreadditionssalte deraf samt farmaceutiske praeparater indeholdende disse
NL190581B (nl) 7beta-(d-2-amino-2-fenylaceetamido)-3-(propenyl)-3-cefem-4-carbonzuur verbinding en farmaceutisch preparaat dat deze verbinding omvat.
DK83485D0 (da) Laegemiddel indeholdende kvartaere 3,4-dihydroisochinoliniumsalte
DK158357C (da) 9-deoxo-9a-(ethyl eller n-propyl)-9a-aza-9a-homoerythromycin a og farmaceutisk acceptable syreadditionssalte deraf samt farmaceutiske praeparater indeholdende disse forbindelser
DK157877C (da) 9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin d og farmaceutisk acceptable syreadditionssalte deraf samt 9-deoxo-9a-aza-9a-homoerythromycin d til anvendelse som udgangsmateriale ved fremstilling deraf
DK164109C (da) Lh-rh-antagonister og deres farmaceutisk acceptable syreadditionssalte og fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende disse
DK162600C (da) Oe4-(2-hydroxycyklohexylmethyl)phenylaaalkansyrederivater og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK166878C (da) Fluorallylaminer og pharmakologisk acceptable syreadditionssalte deraf samt pharmaceutisk praeparat indeholdende disse forbindelser
DK160873C (da) Benzoquinolizinderivater samt farmaceutisk acceptable syreadditionssalte deraf og farmaceutisk middel indeholdende saadanne forbindelser og dettes fremstilling
DK543084D0 (da) Substituerede 3-carbamoyl-1,4-dihydropyridin-forbindelser og saltederaf samt deres fremstilling og anvendelse
GB8319546D0 (en) Pharmaceutical active salts
DK307085D0 (da) 4-phenyl-2-trifluormethyl-1,3-dioxan-5-ylheptensyrederivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK166380C (da) Aminonitrobenzenforbindelse og kosmetisk acceptable syreadditionssalte heraf, analogifremgangsmaade til fremstilling deraf samt farvemiddel indeholdende forbindelsen
DK161076C (da) 2-(2-thienyl-imidazooe4,5-baapyridin-derivater og syreadditionssalte deraf samt farmaceutisk formulering indeholdende en saadan forbindelse
DK99085A (da) Farmaceutiske praeparater indeholdende a-vitaminsyrederivater
DK163512C (da) Substituerede azacyclohexylderivater af rifamyciner og salte deraf, farmaceutiske praeparater indeholdende disse forbindelser samt en fremgangsmaade til fremstilling af forbindelserne
DK158518C (da) Phenylpiperazinderivater og syreadditionssalte deraf, fremgangsmaade til fremstilling deraf samt praeparater indeholdende derivaterne

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
PBP Patent lapsed